ENO2 and in situ carcinoma: One study found a decrease in serum and CSF NSE in patients with CIS compared to healthy controls [62], with some studies showing either no change [43,74] or a negative correlation between plasma NSE levels and EDSS and Multiple Sclerosis Severity Score (MSSS) [75].